Hana Pharm Co Ltd (293480) — Capital Reinvestment Ratio
Latest as of June 2025:
42.57x
Hana Pharm Co Ltd (293480) has a Capital Reinvestment Ratio of 42.57x as of June 2025, meaning it reinvests 43% of its operating cash flow (₩235.15 Million) in capital expenditures (₩10.01 Billion). See 293480 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
42.57x
Capex / Operating Cash Flow
Operating Cash Flow
₩235.15 Million
KRW
Capital Expenditures
₩10.01 Billion
KRW
Data as of
Jun 2025
Most recent filing
Hana Pharm Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Hana Pharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Hana Pharm Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Hana Pharm Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see Hana Pharm Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | ₩25.30 Billion | ₩13.21 Billion | ▼ -34.6% |
| 2023 | 0.80x | ₩18.40 Billion | ₩14.68 Billion | ▼ -31.1% |
| 2022 | 1.16x | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 1.36x | ₩25.66 Billion | ₩34.81 Billion | ▲ +23.3% |
| 2020 | 1.10x | ₩15.58 Billion | ₩17.14 Billion | ▲ +3.4% |
| 2019 | 1.06x | ₩31.72 Billion | ₩33.73 Billion | ▲ +426.7% |
| 2018 | 0.20x | ₩27.59 Billion | ₩5.57 Billion | ▼ -49.7% |
| 2017 | 0.40x | ₩25.38 Billion | ₩10.19 Billion | ▼ -39.8% |
| 2016 | 0.67x | ₩12.46 Billion | ₩8.31 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow